Cytovale tests sepsis diagnostic in COVID-19 patients

By staff writers

April 23, 2020 -- Medical cell technology company Cytovale is set to conduct a pilot study of its rapid diagnostic test for sepsis in patients with suspected SARS-CoV-2 and other respiratory infections. The study is being carried out with support from the U.S. Biomedical Advanced Research and Development Authority (BARDA).

BARDA, which is an office within the U.S. Department of Health and Human Services, is contributing $3.83 million out of the $5.9 million needed for validation and advanced research of Cytovale's rapid sepsis diagnostic system, including the COVID-19 pilot study, and Cytovale is footing the bill for the remainder.

The pilot study is being carried out in partnership with healthcare facilities in Louisiana, which has been hit hard in the coronavirus pandemic. The system uses high-speed imaging, machine learning, and microfluidics to diagnose sepsis in fewer than 10 minutes, according to the company. Rapid testing is crucial for helping to identify serious infections that can result in organ failure and death.

Immunexpress gets CE Mark for sepsis test
Molecular diagnostic company Immunexpress has received the CE Mark in Europe to market and sell its rapid sepsis test.
Study identifies risk factors for death from coronavirus
For individuals with the novel coronavirus disease, several factors were associated with an increased risk of death in a new study, published online March...
C-reactive protein test falls flat in newborns with suspected sepsis
Testing for C-reactive protein is sometimes used as a diagnostic aid for suspected sepsis -- a common, life-threatening complication -- in newborn babies,...
Beckman Coulter floats Access PCT sepsis test in U.S.
Beckman Coulter announced on January 28 that its Access PCT procalcitonin assay is available in the U.S. as a test cleared by the U.S. Food and Drug Administration.
Nanomix mobile, 3-in-1 sepsis test gets CE Mark
Nanomix announced that its S1 assay for serious infections, including sepsis and bacteremia, has received the CE Mark, paving the way for sales in European...

Copyright © 2020

Last Updated ls 4/23/2020 11:34:16 AM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current